Yongjun Wang

Yongjun Wang

From The Department Of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China (J.j., Y.p., X.z., H.z., Q.j., H.l., L.l., C.w., X.m., Yilong Wang, ...

Direct Impact

Concepts for which Yongjun Wang has direct influence:

ischemic stroke
blood pressure
transient ischaemic attack
hazard ratio

External impact

Concepts related to the work of other authors for which Yongjun Wang has influence:

ischemic stroke
blood pressure
maleate injection
publisher correction
intracerebral hemorrhage
32 loci
multiancestry genome-wide

Prominent publications by Yongjun Wang

KOL-Index: 308 RATIONALE: In patients with acute cerebral ischemia, the rate of stroke, myocardial infarction, or death during 90 days was reported to be non-significantly lower with ticagrelor compared with aspirin, with no increase in major hemorrhage. Dual antiplatelet therapy may be more effective in this setting. AIM: To investigate whether ticagrelor combined with aspirin are superior to aspirin ...
Known for
75-100 Mg | High-Risk Transient Ischemic Attack | Composite Endpoint | Stroke Transient
KOL-Index: 306 Importance: Reduction of subsequent disabling stroke is the main goal of preventive treatment in the acute setting after transient ischemic attack (TIA) or minor ischemic stroke. Objective: To evaluate the superiority of ticagrelor added to aspirin in preventing disabling stroke and to understand the factors associated with recurrent disabling stroke. Design, Setting, and Participants: The ...
Known for
30-Day Follow-Up | 28 | Aspirin Acute | Recurrent Disabling
KOL-Index: 80 Background: The inverse association between obesity and outcome in stroke patients (known as the obesity paradox) has been widely reported, yet mechanistic details explaining the paradox are limited. The triglyceride glucose (TYG) index has been proposed as a marker of insulin resistance. We sought to explore possible associations of the TYG index, body mass index (BMI), and stroke outcome. ...
Known for
Modified Rankin | Weight Ischemic | Cox Logistic Regression Model | Triglyceride Glucose Tyg
KOL-Index: 61 Objective: Serum cystatin C (CysC) is a sensitive marker of renal function to predict cardiovascular diseases. We aimed to investigate the predictive value of CysC for clinical outcomes independent of renal function in patients with acute ischemic stroke (AIS). Methods: We measured serum CysC levels in 10,256 AIS patients from Third China National Stroke Registry (CNSR-III). The primary ...
Known for
Observed Stroke | Marker Renal | Primary Major | Cysc Shaped
KOL-Index: 60 OBJECTIVES: There are few studies of spontaneous hemorrhagic transformation (HT) after ischemic stroke (IS), and those that are available do not preclude the use of antithrombotic therapy after admission. We aimed to investigate the frequency and risk factors of spontaneous HT in patients who received no therapy between IS onset and the first instance of neurological imaging. METHODS: We ...
Known for
Onset Initial Imaging | Excess Alcohol Consumption | Acute Stage | Initial Computed Tomography
KOL-Index: 58 High sensitivity C-reactive protein (hsCRP) has been evaluated as a biomarker in stroke and relevant pathological diseases. While its predictive values in several pathological phenotypes have been confirmed, controversy exists among different studies. This review summarizes reports of the predictive values of hsCRP for the diagnosis, etiology, prognosis and mortality of stroke diseases. The ...
Known for
Protein Hscrp | Sensitivity Reactive | Pathological Predictive
KOL-Index: 57 BACKGROUND: Stroke is the second most common cause of mortality and the leading cause of neurological disability, cognitive impairment and dementia worldwide. Nimodipine is a dihydropyridinic calcium antagonist with a role in neuroprotection, making it a promising therapy for vascular cognitive impairment and dementia. METHODS/DESIGN: The NICE study is a multicenter, randomized, ...
Known for
Nimodipine Preventing | Vascular Cognitive | Design Nice

From the Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China (J.J., Y.P., X.Z., H.Z., Q.J., H.L., L.L., C.W., X.M., Yilong Wang, Yongjun Wang); China National Clinical Research Center for Neurological Disease

https://www.g2.com/products/key-opinion-leaders-kols/reviews https://www.bbb.org/us/fl/doral/profile/data-analytics/key-opinion-leaders-0633-92023858 https://www.trustpilot.com/review/keyopinionleaders.com https://www.yelp.com/biz/key-opinion-leaders-miami


© 2022 - Key Opinion Leaders -
Key Opinion Leaders, LLC ,
2025 NW 102 Avenue, Suite 111 Doral , FL   33172